Brief: Bioceltix Pharmaceutical Plant Project Receives Approval From Poland's Enterprise Development Agency
17/04/2025 12:47
April 17 (Reuters) - Bioceltix SA BCXP.WA: RECEIVES POSITIVE EVALUATION FROM POLISH AGENCY FOR ENTERPRISE DEVELOPMENT FOR PHARMACEUTICAL PLANT PROJECT TOTAL PROJECT EXPENSES PLN 49.6 MILLION NET, REQUESTED FUNDING PLN 17.4 MILLION Source text: nEM9BMZRza Further company coverage: BCXP.WA (Reporting by Gdańsk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Bioceltix SA
See all newsBrief: Bioceltix Signs 2 Mln Zlotys Net Deal With Intero For Construction Works
Brief: Bioceltix Receives Permit For Biological Veterinary Drugs Facility
Brief: Bioceltix Veterinary Biological Drug Project InnoBioVet Recommended For 15.1 Million Zloty Subsidy
Brief: Bioceltix Signs Advisory Agreement For FDA Regulatory Support
Brief: Bioceltix Gets GMP Certificate For Wroclaw Veterinary Medicine Facility